Ex vivo nicotine stimulation augments the efficacy of human peripheral blood mononuclear cell-derived dendritic cell vaccination via activating Akt-S6 pathway

Anal Cell Pathol (Amst). 2015:2015:741487. doi: 10.1155/2015/741487. Epub 2015 Aug 13.

Abstract

Our previous studies showed that α7 nicotinic acetylcholine receptor (nAchR) agonist nicotine has stimulatory effects on murine bone marrow-derived semimature DCs, but the effect of nicotine on peripheral blood mononuclear cell- (PBMC-) derived human semimature dendritic cells (hu-imDCs) is still to be clarified. In the present study, hu-imDCs (cultured 4 days) were conferred with ex vivo lower dose nicotine stimulation and the effect of nicotine on surface molecules expression, the ability of cross-presentation, DCs-mediated PBMC priming, and activated signaling pathways were determined. We could demonstrate that the treatment with nicotine resulted in increased surface molecules expression, enhanced hu-imDCs-mediated PBMC proliferation, upregulated release of IL-12 in the supernatant of cocultured DCs-PBMC, and augmented phosphorylation of Akt and ribosomal protein S6. Nicotine associated with traces of LPS efficiently enhanced endosomal translocation of internalized ovalbumin (OVA) and increased TAP-OVA colocalization. Importantly, the upregulation of nicotine-increased surface molecules upregulation was significantly abrogated by the inhibition of Akt kinase. These findings demonstrate that ex vivo nicotine stimulation augments hu-imDCs surface molecules expression via Akt-S6 pathway, combined with increased Ag-presentation result in augmented efficacy of DCs-mediated PBMC proliferation and Th1 polarization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation / drug effects
  • Cell Proliferation / drug effects
  • Coculture Techniques
  • Dendritic Cells / cytology*
  • Endosomes / drug effects
  • Endosomes / metabolism
  • Histocompatibility Antigens Class I / metabolism
  • Humans
  • Interleukin-12 / metabolism
  • Leukocytes, Mononuclear / cytology*
  • Lipopolysaccharides / pharmacology
  • Nicotine / pharmacology*
  • Ovalbumin / metabolism
  • Protein Transport / drug effects
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Ribosomal Protein S6 / metabolism*
  • Signal Transduction / drug effects*
  • Subcellular Fractions / metabolism
  • Up-Regulation / drug effects
  • Vaccination*

Substances

  • Histocompatibility Antigens Class I
  • Lipopolysaccharides
  • Ribosomal Protein S6
  • Interleukin-12
  • Nicotine
  • Ovalbumin
  • Proto-Oncogene Proteins c-akt